A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring

Giuseppe Del Priore, Jeanetta Malanowska-Stega, Shalaby W. Shalaby, Susan Richman

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To conduct a pilot safety and tolerability study of the Ovaprene ring (Poly-Med Inc., Clemson University, Clemson, South Carolina) as a barrier contraceptive. STUDY DESIGN: Open-label, single-arm, observational study in a convenient sample of volunteers. Women meeting inclusion criteria and using another contraceptive method were instructed in proper insertion of the ring at the completion of their menses, with removal at their subsequent menses or 29 days. Baseline Pap smears, vaginal cultures and colposcopy were performed, with follow-up postcoital testing and acceptability questionnaires. RESULTS: Twenty women enrolled: all completed one cycle of use. Rings were inserted properly and retained in place (range, 5-29 days). Patient questionnaires revealed no pain or bleeding, and no colposcopic abnormalities were seen. Semiquantitative cultures yielded no significant changes in vaginal flora. Postcoital testing revealed nonviable sperm (motile/total, mean count/10 high power fields) 2/> 20 in the vaginal pool and 0/0 in cervical mucus. There were no serious adverse effects. CONCLUSION: The Ovaprene device is well tolerated and acceptable to sexually active women and their partners.

Original languageEnglish
Pages (from-to)685-690
Number of pages6
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume54
Issue number11-12
StatePublished - Nov 2009
Externally publishedYes

Fingerprint

Female Contraceptive Devices
Contraceptive Agents
Menstruation
Safety
Cervix Mucus
Papanicolaou Test
Colposcopy
Contraception
Observational Studies
Spermatozoa
Volunteers
Hemorrhage
Pain
Equipment and Supplies
Surveys and Questionnaires

Keywords

  • Barrier contraception
  • Ovaprene
  • Postcoital testing

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring. / Del Priore, Giuseppe; Malanowska-Stega, Jeanetta; Shalaby, Shalaby W.; Richman, Susan.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 54, No. 11-12, 11.2009, p. 685-690.

Research output: Contribution to journalArticle

Del Priore, G, Malanowska-Stega, J, Shalaby, SW & Richman, S 2009, 'A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring', Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 54, no. 11-12, pp. 685-690.
Del Priore, Giuseppe ; Malanowska-Stega, Jeanetta ; Shalaby, Shalaby W. ; Richman, Susan. / A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring. In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 2009 ; Vol. 54, No. 11-12. pp. 685-690.
@article{cf2dc3b6bbb6412da1224dc89361a69f,
title = "A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring",
abstract = "OBJECTIVE: To conduct a pilot safety and tolerability study of the Ovaprene ring (Poly-Med Inc., Clemson University, Clemson, South Carolina) as a barrier contraceptive. STUDY DESIGN: Open-label, single-arm, observational study in a convenient sample of volunteers. Women meeting inclusion criteria and using another contraceptive method were instructed in proper insertion of the ring at the completion of their menses, with removal at their subsequent menses or 29 days. Baseline Pap smears, vaginal cultures and colposcopy were performed, with follow-up postcoital testing and acceptability questionnaires. RESULTS: Twenty women enrolled: all completed one cycle of use. Rings were inserted properly and retained in place (range, 5-29 days). Patient questionnaires revealed no pain or bleeding, and no colposcopic abnormalities were seen. Semiquantitative cultures yielded no significant changes in vaginal flora. Postcoital testing revealed nonviable sperm (motile/total, mean count/10 high power fields) 2/> 20 in the vaginal pool and 0/0 in cervical mucus. There were no serious adverse effects. CONCLUSION: The Ovaprene device is well tolerated and acceptable to sexually active women and their partners.",
keywords = "Barrier contraception, Ovaprene, Postcoital testing",
author = "{Del Priore}, Giuseppe and Jeanetta Malanowska-Stega and Shalaby, {Shalaby W.} and Susan Richman",
year = "2009",
month = "11",
language = "English",
volume = "54",
pages = "685--690",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "11-12",

}

TY - JOUR

T1 - A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring

AU - Del Priore, Giuseppe

AU - Malanowska-Stega, Jeanetta

AU - Shalaby, Shalaby W.

AU - Richman, Susan

PY - 2009/11

Y1 - 2009/11

N2 - OBJECTIVE: To conduct a pilot safety and tolerability study of the Ovaprene ring (Poly-Med Inc., Clemson University, Clemson, South Carolina) as a barrier contraceptive. STUDY DESIGN: Open-label, single-arm, observational study in a convenient sample of volunteers. Women meeting inclusion criteria and using another contraceptive method were instructed in proper insertion of the ring at the completion of their menses, with removal at their subsequent menses or 29 days. Baseline Pap smears, vaginal cultures and colposcopy were performed, with follow-up postcoital testing and acceptability questionnaires. RESULTS: Twenty women enrolled: all completed one cycle of use. Rings were inserted properly and retained in place (range, 5-29 days). Patient questionnaires revealed no pain or bleeding, and no colposcopic abnormalities were seen. Semiquantitative cultures yielded no significant changes in vaginal flora. Postcoital testing revealed nonviable sperm (motile/total, mean count/10 high power fields) 2/> 20 in the vaginal pool and 0/0 in cervical mucus. There were no serious adverse effects. CONCLUSION: The Ovaprene device is well tolerated and acceptable to sexually active women and their partners.

AB - OBJECTIVE: To conduct a pilot safety and tolerability study of the Ovaprene ring (Poly-Med Inc., Clemson University, Clemson, South Carolina) as a barrier contraceptive. STUDY DESIGN: Open-label, single-arm, observational study in a convenient sample of volunteers. Women meeting inclusion criteria and using another contraceptive method were instructed in proper insertion of the ring at the completion of their menses, with removal at their subsequent menses or 29 days. Baseline Pap smears, vaginal cultures and colposcopy were performed, with follow-up postcoital testing and acceptability questionnaires. RESULTS: Twenty women enrolled: all completed one cycle of use. Rings were inserted properly and retained in place (range, 5-29 days). Patient questionnaires revealed no pain or bleeding, and no colposcopic abnormalities were seen. Semiquantitative cultures yielded no significant changes in vaginal flora. Postcoital testing revealed nonviable sperm (motile/total, mean count/10 high power fields) 2/> 20 in the vaginal pool and 0/0 in cervical mucus. There were no serious adverse effects. CONCLUSION: The Ovaprene device is well tolerated and acceptable to sexually active women and their partners.

KW - Barrier contraception

KW - Ovaprene

KW - Postcoital testing

UR - http://www.scopus.com/inward/record.url?scp=77649269548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649269548&partnerID=8YFLogxK

M3 - Article

C2 - 20120902

AN - SCOPUS:77649269548

VL - 54

SP - 685

EP - 690

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 11-12

ER -